216 related articles for article (PubMed ID: 23537861)
1. Targeting the trimolecular complex.
Michels AW
Clin Immunol; 2013 Dec; 149(3):339-44. PubMed ID: 23537861
[TBL] [Abstract][Full Text] [Related]
2. Recognition of Multiple Hybrid Insulin Peptides by a Single Highly Diabetogenic T-Cell Receptor.
Parras D; Solé P; Delong T; Santamaría P; Serra P
Front Immunol; 2021; 12():737428. PubMed ID: 34527002
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response.
Ridgway WM; Ito H; Fassò M; Yu C; Fathman CG
J Exp Med; 1998 Dec; 188(12):2267-75. PubMed ID: 9858513
[TBL] [Abstract][Full Text] [Related]
4. A TCR-like antibody against a proinsulin-containing fusion peptide ameliorates type 1 diabetes in NOD mice.
Matsumoto Y; Kishida K; Matsumoto M; Matsuoka S; Kohyama M; Suenaga T; Arase H
Biochem Biophys Res Commun; 2021 Jan; 534():680-686. PubMed ID: 33208230
[TBL] [Abstract][Full Text] [Related]
5. Molecular targeting of islet autoantigens.
Stadinski B; Kappler J; Eisenbarth GS
Immunity; 2010 Apr; 32(4):446-56. PubMed ID: 20412755
[TBL] [Abstract][Full Text] [Related]
6. Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetes.
Zhang L; Sosinowski T; Cox AR; Cepeda JR; Sekhar NS; Hartig SM; Miao D; Yu L; Pietropaolo M; Davidson HW
J Autoimmun; 2019 Jan; 96():50-58. PubMed ID: 30122420
[TBL] [Abstract][Full Text] [Related]
7. The anti-insulin trimolecular complex in type 1 diabetes.
Michels AW; Nakayama M
Curr Opin Endocrinol Diabetes Obes; 2010 Aug; 17(4):329-34. PubMed ID: 20489610
[TBL] [Abstract][Full Text] [Related]
8. Type 1 diabetes: primary antigen/peptide/register/trimolecular complex.
Sosinowski T; Eisenbarth GS
Immunol Res; 2013 Mar; 55(1-3):270-6. PubMed ID: 22956469
[TBL] [Abstract][Full Text] [Related]
9. How C-terminal additions to insulin B-chain fragments create superagonists for T cells in mouse and human type 1 diabetes.
Wang Y; Sosinowski T; Novikov A; Crawford F; White J; Jin N; Liu Z; Zou J; Neau D; Davidson HW; Nakayama M; Kwok WW; Gapin L; Marrack P; Kappler JW; Dai S
Sci Immunol; 2019 Apr; 4(34):. PubMed ID: 30952805
[TBL] [Abstract][Full Text] [Related]
10. Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope.
Dahan R; Gebe JA; Preisinger A; James EA; Tendler M; Nepom GT; Reiter Y
J Autoimmun; 2013 Dec; 47():83-93. PubMed ID: 24090977
[TBL] [Abstract][Full Text] [Related]
11. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice.
Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP
J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058
[TBL] [Abstract][Full Text] [Related]
12. Blood leukocytes recapitulate diabetogenic peptide-MHC-II complexes displayed in the pancreatic islets.
Vomund AN; Lichti CF; Peterson OJ; Arbelaez AM; Wan X; Unanue ER
J Exp Med; 2021 Jun; 218(6):. PubMed ID: 33822842
[TBL] [Abstract][Full Text] [Related]
13. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.
Kupfer TM; Crawford ML; Pham K; Gill RG
J Immunol; 2005 Aug; 175(4):2309-16. PubMed ID: 16081800
[TBL] [Abstract][Full Text] [Related]
14. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody blocking the recognition of an insulin peptide-MHC complex modulates type 1 diabetes.
Zhang L; Crawford F; Yu L; Michels A; Nakayama M; Davidson HW; Kappler JW; Eisenbarth GS
Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2656-61. PubMed ID: 24550292
[TBL] [Abstract][Full Text] [Related]
16. Antigen presentation in the autoimmune diabetes of the NOD mouse.
Unanue ER
Annu Rev Immunol; 2014; 32():579-608. PubMed ID: 24499272
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Human CD4 T Cells Specific for a C-Peptide/C-Peptide Hybrid Insulin Peptide.
Wiles TA; Hohenstein A; Landry LG; Dang M; Powell R; Guyer P; James EA; Nakayama M; Haskins K; Delong T; Baker RL
Front Immunol; 2021; 12():668680. PubMed ID: 34113344
[TBL] [Abstract][Full Text] [Related]
18. Targeting the trimolecular complex: the pathway towards type 1 diabetes prevention.
Michels AW
Diabetes Technol Ther; 2013 Jun; 15 Suppl 2(Suppl 2):S2-8-S2-12. PubMed ID: 23786298
[TBL] [Abstract][Full Text] [Related]
19. Cloned T cells internalize peptide from bound complexes of peptide and purified class II major histocompatibility complex antigen.
Nag B; Deshpande SV; Sharma SD; Clark BR
J Biol Chem; 1993 Jul; 268(19):14360-6. PubMed ID: 7686154
[TBL] [Abstract][Full Text] [Related]
20. Position β57 of I-A
Gioia L; Holt M; Costanzo A; Sharma S; Abe B; Kain L; Nakayama M; Wan X; Su A; Mathews C; Chen YG; Unanue E; Teyton L
Sci Immunol; 2019 Aug; 4(38):. PubMed ID: 31471352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
